Andreas Halvorsen acquired 8.02 Million NewAmsterdam Pharma Company NV shares worth $161 Million. That's 0.61% of their equity portfolio (42nd largest holding). The investor owns 20.25% of the outstanding NewAmsterdam Pharma Company NV stock. The stake costed the investor $90.1 Million, netting the investor a gain of 79% so far.